Phase I Trial of BYL719 in Combination With Concurrent Cisplatin-based Chemoradiotherapy in Patients With Locoregionally Advanced Squamous Cell Carcinoma of Head and Neck (LA-SCCHN)
Phase of Trial: Phase I
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Alpelisib (Primary) ; Cisplatin
- Indications Head and neck cancer; Squamous cell cancer
- Focus Adverse reactions
- 02 Feb 2018 Planned End Date changed from 1 Mar 2019 to 1 Mar 2020.
- 02 Feb 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Sep 2019.
- 21 Jun 2016 Status changed from not yet recruiting to recruiting.